Page 37 - Quest Diagnostics News Today

Quest Diagnostics (NYSE:DGX – Free Report) had its target price upped by Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. SVB Leerink initiated coverage on […]

Golden State Equity Partners boosted its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,035 shares of the medical research company’s stock after acquiring an additional 251 shares during the […]

Signaturefd LLC grew its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 43.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,374 shares of the medical research company’s stock after purchasing an additional 418 shares during the quarter. Signaturefd […]

The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences.

Yousif Capital Management LLC decreased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,102 shares of the medical research company’s stock after selling 1,236 shares during the […]

Plus 19 other New Jersey companies among the best in the U.S.

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective increased by equities researchers at Barclays from $138.00 to $144.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 7.25% from the company’s […]

Motley Fool Asset Management LLC trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. […]

Bahl & Gaynor Inc. lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 212,951 shares of the medical research company’s stock after buying an additional 29,469 shares during […]

Motley Fool Asset Management LLC reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. Motley Fool Asset […]